Constance Compton, APRN
Critical Care Medicine · Jacksonville, FLNPI 1750954046
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations.
Across 56 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$230
- AstraZeneca$152
- Boehringer Ingelheim$125
- Regeneron Healthcare Solutions, Inc.$105
- Viatris Specialty LLC$96
- Grifols USA, LLC$77
- plus $503 from 15 others
What the payments were for
- Food & beverage$1,288100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $230 |
| AstraZeneca | 9 | $152 |
| Boehringer Ingelheim | 5 | $125 |
| Regeneron Healthcare Solutions, Inc. | 3 | $105 |
| Viatris Specialty LLC | 4 | $96 |
| Grifols USA, LLC | 3 | $77 |
| United Therapeutics Corporation | 2 | $63 |
| Jazz Pharmaceuticals Inc. | 3 | $61 |
| Actelion Pharmaceuticals US, Inc. | 2 | $51 |
| Inogen, Inc. | 2 | $49 |
| GSK | 2 | $45 |
| AbbVie | 2 | $39 |
| Merck | 1 | $31 |
| Insmed, Inc. | 1 | $30 |
| Shionogi Inc | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Electromed, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Baxter Healthcare | 1 | $16 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$1,288 in reported general payments places this provider in the 75th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Jacksonville
- Eddy GutierrezJacksonville$315K
- Nathan WaldronJacksonville$17K
- Pramod GuruJacksonville$11K
- Joseph ShiberJacksonville$10K
- Jorge TrabancoJacksonville$7K
- Louis GuzziOrlando$635K
- Fortune AlabiKissimmee$587K
- Debabrata BandyopadhyayTampa$398K
- Fred UmehKissimmee$371K
- Amit TandonWesley Chapel$338K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.